Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 8/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7690546 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRFDPSSMPD1CES2 | |
| SCHEMBL2822500 | 0.92 | ALDH1A1 (0.46) | ALDH1A1TSHRFDPSTP53SMPD1 | |
| SCHEMBL11102231 | 0.83 | ALDH1A1 (0.42) | ALDH1A1TSHRFDPSTP53SMPD1 | |
| SCHEMBL809272 | 0.81 | TSHR (0.41) | ALDH1A1TSHRFDPSTP53CES2 | |
| SCHEMBL6134859 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TSHRFDPSTP53SMPD1 | |
| SCHEMBL27003896 | 0.79 | GPR84 (0.59) | ALDH1A1TSHR | |
| SCHEMBL7679775 | 0.78 | GGPS1 (0.45) | ALDH1A1TSHRFDPSTP53SMPD1 | |
| SCHEMBL28898288 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRFDPSSMPD1CES2 | |
| SCHEMBL1410499 | 0.78 | ALDH1A1 (0.44) | ALDH1A1TSHRFDPSTP53SMPD1 | |
| SCHEMBL8736291 | 0.78 | ALDH1A1 (0.44) | ALDH1A1TSHRFDPSTP53SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020028970-A1 | SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | THE CLOROX COMPANY | 2002-03-07 | — | — | US | disclosed |
| WO-2001002343-A1 | IMPROVED SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | THE CLOROX COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028970-A1 | SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | DDT, DDC, MLYCD | ALDH1A1 370/4885TSHR 1922/4885FDPS 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.